Capricor Therapeutics, Inc. (CAPR)
6.81
+0.52
(+8.27%)
USD |
NASDAQ |
Aug 24, 16:00
6.80
-0.01
(-0.15%)
After-Hours: 20:00
Capricor Therapeutics Shareholders Equity (Quarterly) : 246.22M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 246.22M |
| March 31, 2026 | 278.70M |
| December 31, 2025 | 305.79M |
| September 30, 2025 | 83.87M |
| June 30, 2025 | 104.98M |
| March 31, 2025 | 127.65M |
| December 31, 2024 | 145.46M |
| September 30, 2024 | 68.26M |
| June 30, 2024 | 11.50M |
| March 31, 2024 | 18.43M |
| December 31, 2023 | 22.60M |
| September 30, 2023 | -1.788M |
| June 30, 2023 | 2.731M |
| March 31, 2023 | 6.206M |
| December 31, 2022 | 11.79M |
| September 30, 2022 | 15.43M |
| June 30, 2022 | 18.73M |
| March 31, 2022 | 24.64M |
| December 31, 2021 | 31.37M |
| September 30, 2021 | 36.74M |
| June 30, 2021 | 33.38M |
| March 31, 2021 | 36.38M |
| December 31, 2020 | 28.20M |
| September 30, 2020 | 30.41M |
| June 30, 2020 | 31.65M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.593M |
| December 31, 2019 | 6.839M |
| September 30, 2019 | 3.570M |
| June 30, 2019 | 2.364M |
| March 31, 2019 | 3.740M |
| December 31, 2018 | 4.616M |
| September 30, 2018 | 6.980M |
| June 30, 2018 | 9.631M |
| March 31, 2018 | 10.53M |
| December 31, 2017 | 11.23M |
| September 30, 2017 | -4.271M |
| June 30, 2017 | -6.586M |
| March 31, 2017 | -7.192M |
| December 31, 2016 | -4.003M |
| September 30, 2016 | 0.0491M |
| June 30, 2016 | -5.116M |
| March 31, 2016 | -1.083M |
| December 31, 2015 | -1.032M |
| September 30, 2015 | 1.926M |
| June 30, 2015 | 4.555M |
| March 31, 2015 | 7.324M |
| December 31, 2014 | -6.249M |
| September 30, 2014 | -4.472M |
| June 30, 2014 | -3.085M |
| March 31, 2014 | -1.659M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| REGENXBIO, Inc. | 71.76M |
| Cytokinetics, Inc. | -173.49M |
| Emergent BioSolutions, Inc. | 341.40M |
| Rigel Pharmaceuticals, Inc. | 425.42M |
| Ironwood Pharmaceuticals, Inc. | -161.84M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 368.74M |
| Total Liabilities (Quarterly) | 122.52M |
| Debt to Equity Ratio | 0.3698 |
| Current Ratio | 7.346 |
| Net Debt Paydown Yield | -1.24% |